HA

Haresh Arjanbhai Kalotra

Active Director Director DIN 11532885
DIN 11532885 First appointment Feb 2026 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Haresh Arjanbhai Kalotra

Data last updated:

Haresh Arjanbhai Kalotra is a Director at Melayurveda (India) Private Limited (since 2026). The company operates in Healthcare.

DIN 11532885
Primary Designation Director
Industry Healthcare
First Appointment 08 Feb 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Melayurveda (India) Private Limited U47720GJ2026PTC173245
Director08 Feb 20262026Active

Board colleagues of Haresh Arjanbhai Kalotra

NameDINCompanyDesignation
Jeegarsinh Vishnubhai Zala11532886Melayurveda (India) Private LimitedDirector

Directorship timeline

Open interactive timeline →
Melayurveda (India) Private Limited
Premium access

Shareholding and investment profile for Haresh Arjanbhai Kalotra

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Haresh Arjanbhai Kalotra

Haresh Arjanbhai Kalotra currently holds 1 directorship: Melayurveda (India) Private Limited (Director, since 08 Feb 2026).

Haresh Arjanbhai Kalotra was first appointed on 08 Feb 2026 as Director at Melayurveda (India) Private Limited.

The current boards of Haresh Arjanbhai Kalotra's companies include Jeegarsinh Vishnubhai Zala (Melayurveda (India) Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available